Circulating DHEA-S levels and major cardiovascular outcomes in chronic Chagas cardiomyopathy: A prospective cohort study

Lyda Z. Rojas, Sergio Alejandro Gómez-Ochoa, Luis E. Echeverría, Paula Katherine Bautista-Niño, Lukas Hunziker, Michele F. Eisenga, Taulant Muka

Research output: Articles / NotesScientific Articlepeer-review

1 Scopus citations


Objective: To analyze the association of circulating dehydroepiandrosterone sulfate (DHEA-S) levels with cardiovascular outcomes in patients with chronic Chagas cardiomyopathy (CCM) diagnosis. Background: DHEA-S is among the main endogenous steroid hormones. Some studies have suggested a relevant role of this hormone in infections and the setting of CCM. Nevertheless, no study has evaluated the prognostic role of DHEA-S in CCM patients. Methods: Prospective cohort study. Patients with CCM and reduced ejection fraction were included. We explored the association of DHEA-S levels with NT-proBNP levels and echocardiographic variables using linear regression models. Next, by using Cox Proportional Hazard models, we examined whether levels of DHEA-S could predict a composite outcome (CO) including all-cause mortality, cardiac transplantation, and implantation of a left ventricular assist device (LVAD). Results: Seventy-four patients were included (59% males, median age: 64 years). After adjustment for confounding factors, high DHEA-S levels were associated with better LVEF, lower left atrium volume, end-systolic volume of the left ventricle and lower NT-proBNP levels. 43% of patients experienced the CO during a median follow-up of 40 months. Increased levels of DHEA-S were associated with a lower risk of developing the CO (HR 0.43; 95%CI 0.21-0.86). Finally, adding DHEA-S to the multivariate model did not improve the prediction of the CO, but substituting NT-proBNP in the model with DHEA-S showed similar performance. Conclusions: In patients with CCM, higher DHEA-S levels were associated with lower mortality, heart transplantation, and LVAD implantation. Further larger studies are required to confirm our results and assess causality.

Original languageEnglish
Pages (from-to)90-95
Number of pages6
JournalInternational Journal of Cardiology
StatePublished - 15 Feb 2022
Externally publishedYes


  • Chagas cardiomyopathy
  • Chagas disease
  • DHEA-S
  • Heart transplantation
  • Heart-assist devices
  • Mortality
  • Peptide Fragments
  • Prognosis
  • Prospective Studies
  • Humans
  • Middle Aged
  • Male
  • Chagas Disease
  • Stroke Volume
  • Chagas Cardiomyopathy
  • Dehydroepiandrosterone
  • Natriuretic Peptide, Brain
  • Biomarkers
  • Heart Failure
  • Cardiomyopathies
  • Female


Dive into the research topics of 'Circulating DHEA-S levels and major cardiovascular outcomes in chronic Chagas cardiomyopathy: A prospective cohort study'. Together they form a unique fingerprint.

Cite this